Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $138.4K in total
- 2
- 13F holdersQ2 2026, +31 vs. previous quarter
- 219
- 13F valueReported value at the end of Q2 2026
- $2.98B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding LEGN, Q2 2026
1 superinvestor reports holding Legend Biotech Corp on Form 13F. Percentages are the stock's share of each portfolio.
HHLR Advisors (Hillhouse)
Zhang Lei
20.8%
Legend Biotech Corp's share of the portfolio
- Shares
- 5,984,550
- Value
- $172.8M
Latest insider trades
Open-market purchases and sales by Legend Biotech Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)4:15 PM ET | Sep 21 | 2 days | Santos Carlos EChief Financial Officer | SSale | −5.43K | $9.14 | −$49.6K | −27.6%14.2K after | |
| Jul 2, 2026 (view filing)4:05 PM ET | Jun 30 | 2 days | Casey Patrick JohnDirector | SSale | −6.00K | $14.80 | −$88.8K | −11.0%48.6K after | |
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Huang YingChief Executive Officer | SSale | −5.57K | $14.78 | −$82.3K | −2.2%241.9K after | |
| Mar 27, 2026 (view filing) | Mar 25 | 2 days | Huang YingChief Executive Officer | SSale | −9.94K | $8.77 | −$87.1K | −3.9%247.4K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Legend Biotech Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 29,093,899 | $840.2M | 0.04% | +3,397,159+13.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 8,137,638 | $235.0M | 2.45% | +450,000+5.9% | Added |
| Suvretta Capital Management, LLC | 7,070,000 | $204.2M | 4.29% | −511,029−6.7% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 5,984,550 | $172.8M | 20.77% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,726,534 | $136.5M | 0.00% | +41,991+0.9% | Added |
| Westfield Capital Management Co LP | 4,430,063 | $127.9M | 0.42% | −1,333,412−23.1% | Reduced |
| Goldman Sachs Group Inc | 3,662,315 | $105.8M | 0.01% | +2,198,203+150.1% | Added |
| Point72 Asset Management, L.P. | 3,076,124 | $88.8M | 0.14% | −809,893−20.8% | Reduced |
| Kynam Capital Management, LP | 3,001,205 | $86.7M | 4.79% | +1,424,910+90.4% | Added |
| Assenagon Asset Management S.A. | 1,915,056 | $55.3M | 0.07% | +1,915,056 | New |